 | • レポートコード：MRC2108A123 • 出版社/出版日：Mordor Intelligence / 2021年7月26日 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、診断画像の世界市場規模が、2021年から2026年の間に年平均約6.1％成長すると予測しています。本調査レポートは、世界の診断画像市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、モダリティ別（MRI、CT、超音波、X線、核画像）分析、用途別（心臓病、腫瘍、神経疾患、整形外科、消化器疾患）分析、エンドユーザー別（病院、診断センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・診断画像の世界市場規模：モダリティ別（MRI、CT、超音波、X線、核画像） ・診断画像の世界市場規模：用途別（心臓病、腫瘍、神経疾患、整形外科、消化器疾患） ・診断画像の世界市場規模：エンドユーザー別（病院、診断センター、その他） ・診断画像の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Canon Medical Systems Corporation、Carestream Health Inc.、Esaote SpA、FUJIFILM Holdings Corporation、GE Healthcare、Hitachi Medical Systems、Hologic Corporation、Koninklijke Philips N.V.,、Shimadzu Medical、Siemens Healthineers、Mindray Medical International Limited 、Browns Medical Imaging (BMI)、Samsung Electronics Co., Ltd.、Koning Corporation） ・市場機会/将来の見通し |
The Diagnostic Imaging Market is expected to register a CAGR of nearly 6.1% during the forecast period. With the emergence of COVID-19, a significant positive impact on the diagnostic imaging market was also observed. As many of these devices such as CT is one of the primary tools for monitoring COVID-19 patients. As per an article by Fleischner Society (Rubin et al. 2020), an ideal diagnostic approach for COVID-19 is both chest CT along PCR tests to ensure the highest sensitivity. Thus, this is likely to augment the market growth.
The major factors augmenting the growth of the diagnostic imaging market include the rise in the prevalence of chronic diseases, increased adoption of advanced technologies in medical imaging, and a rise in the geriatric population.
The burden of chronic diseases is on the rise globally, and medical imaging procedures play a crucial role in the accurate diagnosis of chronic diseases. The increase in the aging population and changes in societal behavior are contributing to a steady increase in these common and costly long-term health problems. Most of the deaths by chronic diseases are attributable to cancer, cardiovascular diseases, obesity, and diabetes. According to GLOBOCAN, in 2020, about 19.3 million new cases of cancer were reported worldwide and this number is expected to increase to 30.2 million in the year 2040. The most affected would be the emerging markets, as the population growth is anticipated to be most significant in developing areas.
New models for therapy and diagnoses are being developed, which provide precise results, help in early detection of diseases, and help minimize the cost of treating these diseases. With the increasing disposable income, people are becoming capable enough to have access to imaging procedures for early detection of diseases.
Furthermore, the medical imaging field has advanced at a great pace, stimulated by advances in digital and communication technologies. New imaging techniques that reveal greater anatomical details are available in most of the diagnostic labs and hospitals. The aim is to improve access and precision, decrease cost, and make the impact of radiation less harmful. The trend is shifting from fixed to portable equipment. For example, until recently, size and electricity requirement have hindered the proper use of ultrasound. Today, smaller ultrasound equipment can provide color-flow Doppler imaging, relying on battery power solely.
Key Market Trends
Mid Range Scanners (~64-Slice) Segment under Computed Tomography is expected to Account for Largest Market Share during the Forecast Period
The computed tomography (CT) scanners experienced tremendous growth in the market studied due to the outbreak of COVID-19. Companies took several definite measures in order to keep up with the growing demand for scanners all over the world. For instance, in February 2020, with the rapidly growing COVID-19 cases Samsung NeuroLogica ramped up the production of its 32-slice CT scanner, “mobile BodyTom”. It allows scanning of COVID-19 patients at the point of care due to its internal shielded design and at the same time minimizes exposure to the virus. Hence, owing to such instances, the market is expected to boost with the emergence of COVID-19.
Mid-range CT scanners are better for performing angiography in comparison with low-range CT scanners. Its characteristics such as high speed and sensitivity allow healthcare professionals to view the walls of arteries for plaque formation, and to observe the tiniest of vessels and arterial branches and therefore are well suited for cardiac studies.
In order to grow their presence in the market, companies are continuously engaged in the development of new products. For instance, in January 2020, Allengers in collaboration with Canon Medical Systems Corporation introduced a new CT scanner in the market “ACUTOM 32” which is a 32 slice CT scanner featured with wide bore gantry of 32 cm, about 2.0MHU X-ray tube and about 0.75 seconds of rotation time.
Furthermore, in April 2019, Columbia Asia Hospital Mysuru, India deployed a state-of-the-art computed tomography with 64 slice in it’s hospital with an aim to enhance the diagnostic procedures. Thus, rising adoption of these CT scanners is further expected to flourish the market growth.
North America accounted for the Largest Share in the Global Market
North America is found to hold a major share of the diagnostic imaging market and is expected to show a similar trend over the forecast period, without significant fluctuations. Due to the outbreak of COVID-19 a profound impact on the market studied is also expected to observe. The American College of Radiology (ACR), which represents nearly 40,000 radiologists in the United States, issued guidance that CTs and X-rays should not be used as a first-line tool to diagnose or screen for COVID-19, as it is highly contagious.
The United States contributes to the major share in the diagnostic imaging market, which can be attributed to the increasing technological advances, higher affordability rates from the population, and the number of diagnostic procedures increasing on a yearly basis. In November 2019, Hologic Inc. received the US Food and Drug Administration (FDA) approval for its 3DQuorum Imaging Technology, powered by Genius AI, for breast cancer detection.
Also, with the presence of well-established healthcare facilities, increasing demand for advanced healthcare systems among the aging population, and increasing prevalence of chronic diseases, the market is expected to grow in the forecast period. The growing number of neurological disorders such as brain tumors is also expected to propel market growth. As per the National Brain Tumor Society, in 2020, 700,000 people in the United States are living with a brain tumor, and around 87,000 as expected to be diagnosed with a brain tumor. Thus, with the aforementioned factors the market is expected to propel in this region during the forecast period.
Competitive Landscape
The market studied is fragmented owing to the presence of several players in the market. Some of the major players in the market are Siemen Healthineers, Koninklijke Philips N.V., GE Healthcare, Hitachi Medical Systems, Hologic Corporation, Mindray Medical International Limited and others. The market players are focusing on R&D to develop technologically advanced products in order to reduce the cost and side effects associated with the products. The barriers for the new entrants are high in this industry, and hence few major market players hold the maximum market share.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Increased Adoption of Advanced Technologies in Medical Imaging
4.2.3 Increase in the Geriatric Population
4.3 Market Restraints
4.3.1 Expensive Procedures and Equipment
4.3.2 Side Effects of Diagnostic Imaging
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Modality
5.1.1 MRI
5.1.1.1 Low and mid field MRI systems (less than 1.5 T)
5.1.1.2 High field MRI systems (1.5-3 T)
5.1.1.3 Very High, and Ultra High Field MRI Systems (3T and more)
5.1.2 Computed Tomography
5.1.2.1 Low End Scanners (~16-Slice)
5.1.2.2 Mid Range Scanners (~64-Slice)
5.1.2.3 High End Scanners (128-Slice and More)
5.1.3 Ultrasound
5.1.3.1 2D Ultrasound
5.1.3.2 3D Ultrasound
5.1.3.3 Others
5.1.4 X-Ray
5.1.4.1 Analog Systems
5.1.4.2 Digital Systems
5.1.5 Nuclear Imaging
5.1.5.1 Positron Emission Tomography (PET)
5.1.5.2 Single Photon Emission Computed Tomography (SPECT)
5.1.6 Fluoroscopy
5.1.7 Mammography
5.2 By Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Orthopedics
5.2.5 Gastroenterology
5.2.6 Gynecology
5.2.7 Other Applications
5.3 By End-User
5.3.1 Hospital
5.3.2 Diagnostic Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Carestream Health Inc.
6.1.3 Esaote SpA
6.1.4 FUJIFILM Holdings Corporation
6.1.5 GE Healthcare
6.1.6 Hitachi Medical Systems
6.1.7 Hologic Corporation
6.1.8 Koninklijke Philips N.V.,
6.1.9 Shimadzu Medical
6.1.10 Siemens Healthineers
6.1.11 Mindray Medical International Limited
6.1.12 Browns Medical Imaging (BMI)
6.1.13 Samsung Electronics Co., Ltd.
6.1.14 Koning Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS